One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-147769
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 2 |
Affiliation: Hospital Universitari i Politècnic La Fe, University of Debrecen, University Cancer Institute Toulouse Oncopole, Roswell Park Cancer Institute, Vanderbilt University Medical Center, Nagasaki University Hospital, Catholic University of Korea, Instytut Hematologii i Transfuzjologi, University of Chicago Medical Center, Hôpital Saint-Louis, University of Southern California, Ghent University Hospital, Princess Margaret Cancer Centre, The University of Texas MD Anderson Cancer Center, Hospices Civils de Lyon, University Hospital Ulm, University of Fukui Hospital, Cornell University, New York Hospital Queens, Presbyterian Hospital, NewYork–Presbyterian HospitalResults from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 302 Patients with Relapsed or Refractory (r/r) Acute Myeloid Leukemia after Intensive Chemotherapy (ASTRAL-2 Study)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
